Volume 51, Issue 7 p. 1730
Back Cover
Free Access

Back Cover: Switching the Targeting Pathways of a Therapeutic Antibody by Nanodesign (Angew. Chem. Int. Ed. 7/2012)

Dr. Sanjib Bhattacharyya

Dr. Sanjib Bhattacharyya

Department of Biochemistry and Molecular Biology, Guggenheim 1311B, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (USA)

Search for more papers by this author
Dr. Raman Deep Singh

Dr. Raman Deep Singh

Department of Biochemistry and Molecular Biology, Guggenheim 1311B, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (USA)

Thoracic Disease Research Unit, Mayo Clinic, Rochester, MN 55905 (USA)

Search for more papers by this author
Dr. Richard Pagano

Dr. Richard Pagano

Thoracic Disease Research Unit, Mayo Clinic, Rochester, MN 55905 (USA)

Deceased

Search for more papers by this author
Dr. J. David Robertson

Dr. J. David Robertson

Department of Chemistry and University of Missouri Research Reactor, University of Missouri, Columbia, MO 65211 (USA)

Search for more papers by this author
Dr. Resham Bhattacharya

Dr. Resham Bhattacharya

Department of Biochemistry and Molecular Biology, Guggenheim 1311B, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (USA)

Search for more papers by this author
Dr. Priyabrata Mukherjee

Corresponding Author

Dr. Priyabrata Mukherjee

Department of Biochemistry and Molecular Biology, Guggenheim 1311B, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (USA)

Biomedical Engineering, Mayo Clinic, Rochester, MN 55905 (USA)

Cancer Center, College of Medicine, Mayo Clinic, Rochester, MN 55905 (USA)

Department of Biochemistry and Molecular Biology, Guggenheim 1311B, College of Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905 (USA)Search for more papers by this author
First published: 16 December 2011

Graphical Abstract

Gold nanoparticles can be used as a scaffold to elucidate the mechanism of endocytosis of cetuximab and its nanoconjugates, as well as the switching of endocytic pathways (caveolar versus pinocytotic) in pancreatic cancer cells, as demonstrated by P. Mukherjee and co-workers in their Communication on page 1563 ff. Tailoring the mechanism of endocytosis may be useful for targeting specific intracellular pathways to minimize the side effects of pharmaceutical compounds.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.